Experts call for risk-benefit talks on lab-modified pathogens

Lisa Schnirring | Staff Writer | CIDRAP NewsJul 15, 2014Their consensus statement calls for better tools to weigh risks and benefits.Share Tweet Email Print & PDF
Jul 15, 2014

Their consensus statement calls for better tools to weigh risks and benefits.

Facebook
Twitter
LinkedIn
Pinterest